Proteintech, best known for its sprawling antibody catalog, is taking a sharper swing at AI-powered life sciences. The company today announced the launch of Able AI, a new digital tool designed to cut through the noise of antibody selection and speed up research workflows. If you’ve ever sifted through hundreds of antibody options—each with technical... Read More